C130H145FN26O11S2 — CID 162038393
(2S,6R)-2,6-dimethyl-4-[4-[6-(1-methylpyrazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;5-(2-fluoro-4-methoxy-3-pyridinyl)-3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-1H-isoindole;3-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-[6-(1-methylpyrazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]morpholine (PubChem CID 162038393) has the molecular formula C130H145FN26O11S2 and a molecular weight of 2330.89 g/mol. Its IUPAC name is (2S,6R)-2,6-dimethyl-4-[4-[6-(1-methylpyrazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;5-(2-fluoro-4-methoxy-3-pyridinyl)-3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-1H-isoindole;3-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-[6-(1-methylpyrazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]morpholine.
| Compound Name | (2S,6R)-2,6-dimethyl-4-[4-[6-(1-methylpyrazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;5-(2-fluoro-4-methoxy-3-pyridinyl)-3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-1H-isoindole;3-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-[6-(1-methylpyrazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]morpholine |
|---|---|
| PubChem CID | 162038393 |
| Molecular Formula | C130H145FN26O11S2 |
| Molecular Weight | 2330.89 g/mol |
| Exact Mass | 2329.10 |
| IUPAC Name | (2S,6R)-2,6-dimethyl-4-[4-[6-(1-methylpyrazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;5-(2-fluoro-4-methoxy-3-pyridinyl)-3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-1H-isoindole;3-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-[6-(1-methylpyrazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]morpholine |
| SMILES | CC(C)Oc1ccc2c(c1)C(c1ccnc(N3CCN(C)CC3)c1)=NC2.CC(C)Oc1ccc2c(c1)C(c1ccnc(N3CCN(S(C)(=O)=O)CC3)c1)=NC2.CC(C)Oc1ccc2c(c1)C(c1ccnc(N3CCOCC3)c1)=NC2.COc1ccnc(F)c1-c1ccc2c(c1)C(c1ccnc(N3CCN(S(C)(=O)=O)CC3)c1)=NC2.C[C@@H]1CN(c2cc(C3=NCc4ccc(-c5cnn(C)c5)cc43)ccn2)C[C@H](C)O1.Cn1cc(-c2ccc3c(c2)C(c2ccnc(N4CCOCC4)c2)=NC3)cn1 |
| InChI | InChI=1S/C24H24FN5O3S.C23H25N5O.C21H21N5O.C21H26N4O3S.C21H26N4O.C20H23N3O2/c1-33-20-6-8-27-24(25)22(20)16-3-4-18-15-28-23(19(18)13-16)17-5-7-26-21(14-17)29-9-11-30(12-10-29)34(2,31)32;1-15-12-28(13-16(2)29-15)22-9-18(6-7-24-22)23-21-8-17(4-5-19(21)10-25-23)20-11-26-27(3)14-20;1-25-14-18(13-24-25)15-2-3-17-12-23-21(19(17)10-15)16-4-5-22-20(11-16)26-6-8-27-9-7-26;1-15(2)28-18-5-4-17-14-23-21(19(17)13-18)16-6-7-22-20(12-16)24-8-10-25(11-9-24)29(3,26)27;1-15(2)26-18-5-4-17-14-23-21(19(17)13-18)16-6-7-22-20(12-16)25-10-8-24(3)9-11-25;1-14(2)25-17-4-3-16-13-22-20(18(16)12-17)15-5-6-21-19(11-15)23-7-9-24-10-8-23/h3-8,13-14H,9-12,15H2,1-2H3;4-9,11,14-16H,10,12-13H2,1-3H3;2-5,10-11,13-14H,6-9,12H2,1H3;4-7,12-13,15H,8-11,14H2,1-3H3;4-7,12-13,15H,8-11,14H2,1-3H3;3-6,11-12,14H,7-10,13H2,1-2H3/t;15-,16+;;;; |
| InChIKey | YWYIHYSGDGFROF-AESNGMONSA-N |
| XLogP | 17.17 |
| TPSA | 362.08 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 170 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2330.89 |
| LogP ≤ 5 | 17.17 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 35 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|